基于CT的栖息地成像与放射学和临床病理学相结合,用于无创预测肝细胞癌的微血管侵袭
CT-based habitat imaging integrated with radiomics and clinicopathology for noninvasive prediction of microvascular invasion in hepatocellular carcinoma.
CT-based habitat imaging integrated with radiomics and clinicopathology for noninvasive prediction of microvascular invasion in hepatocellular carcinoma.
开发并验证一种基于CT的栖息地影像模型,该模型整合了瘤内微环境异质性分析,用于肝细胞癌(HCC)微血管侵犯(MVI)的无创术前预测,以解决传统影像组学在表征瘤内异质性方面的局限性。本回顾性研究纳入216例经病理确诊并接受切除术的HCC患者。收集术前门静脉期增强CT及相应的术后组织病理学MVI状态。提取栖息地(功能异质性亚区)特征和传统影像组学特征,计算栖息地风险评分和影像组学评分。通过单因素/多因素分析筛选出的临床-病理因素(Edmondson分级、p53/CD10表达、肿瘤直径)被整合至预测模型,并以列线图形式可视化。采用AUC、校准曲线和决策曲线分析(DCA)评估性能。DeLong检验用于比较ROC曲线。在训练集中,联合模型的AUC为0.862(95% CI:0.797-0.926);在验证集中,AUC为0.814(95% CI:0.710-0.918),均显著优于各单一模型(均P < 0.05)。校准曲线显示良好的一致性(Hosmer-Lemeshow P = 0.60)。DCA表明在15%-65%的阈值范围内具有净获益。DeLong检验证实联合模型的AUC高于临床模型(Z = -3.21,P < .05)和纯影像组学模型(Z = -2.05,P < .05)。基于CT的栖息地影像模型可量化瘤内异质性,并结合临床病理数据,为HCC术前MVI风险分层提供了可靠的无创工具,具有较强的临床潜力。
To develop and validate a CT-based habitat imaging model incorporating intratumoral microenvironment heterogeneity analysis for noninvasive preoperative prediction of microvascular invasion (MVI) in hepatocellular carcinoma (HCC), addressing limitations of conventional radiomics in characterizing intra-tumor heterogeneity. This retrospective study included 216 patients with pathologically confirmed HCC undergoing resection. Preoperative portal venous phase contrast-enhanced CT and corresponding postoperative histopathologic MVI status were collected. Habitat (functional heterogeneous subregion) and conventional radiomic features were extracted. A habitat risk score and radiomic score were calculated. Clinical-pathologic factors (Edmondson grade, p53/CD10 expression, tumor diameter) identified via univariate/multivariate analyzes were integrated into a predictive model visualized as a nomogram. Performance was assessed by AUC, calibration curves, and decision curve analysis (DCA). DeLong's test compared ROC curves. In the training set, the combined model achieved an AUC of 0.862 (95% CI: 0.797-0.926); in the validation set, AUC was 0.814 (95% CI: 0.710-0.918), both significantly outperforming individual models (all P < 0.05). Calibration curves showed good agreement (Hosmer-Lemeshow P = 0.60). DCA indicated net benefit at thresholds of 15%-65%. DeLong's test confirmed the combined model had higher AUC than the clinical model (Z = -3.21, P < .05) and radiomics-only model (Z = -2.05, P < .05). The CT-based habitat imaging model quantified intratumoral heterogeneity and, combined with clinicopathologic data, provided a reliable noninvasive tool for preoperative MVI risk stratification in HCC, with strong clinical potential.
Shuangxi Chen, Xushuang Qin, Shanni Dong, Xiaoshu Zhu, Yang Liu, Jun Chen, et al. CT-based habitat imaging integrated with radiomics and clinicopathology for noninvasive prediction of microvascular invasion in hepatocellular carcinoma.. Frontiers in oncology. 2026; doi:10.3389/fonc.2026.1832615.
Shuangxi Chen, Xushuang Qin, Shanni Dong, Xiaoshu Zhu, Yang Liu, Jun Chen, et al (2026). CT-based habitat imaging integrated with radiomics and clinicopathology for noninvasive prediction of microvascular invasion in hepatocellular carcinoma.. Frontiers in oncology. https://doi.org/10.3389/fonc.2026.1832615
Shuangxi Chen, Xushuang Qin, Shanni Dong, Xiaoshu Zhu, Yang Liu, Jun Chen, et al. CT-based habitat imaging integrated with radiomics and clinicopathology for noninvasive prediction of microvascular invasion in hepatocellular carcinoma.[J]. Frontiers in oncology, 2026 doi:10.3389/fonc.2026.1832615.
翻译全文 · AI 文献问答 · PDF 原文下载 · 引用导出